EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice

Ching-Wei Yang iD, Hsuan-Miao Liu iD, Zi-Yu Chang iD, Geng-Hao Liu iD, Hen-Hong Chang iD, Po-Yu Huang, Tzung-Yan Lee iD

International Journal of Molecular Sciences · 12.05.2024 · 25 (10) · 5274

DOI: 10.3390/ijms25105274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.05.2024. Verfasst von Ching-Wei Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan. Hauptthemen laut MEDLINE: Isoflavones, Gastrointestinal Microbiome, Diet, High-Fat, Receptors, Cytoplasmic and Nuclear. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Memorial Hospital, Linkou, Taiwan, National Science and Technology Council, Taipei, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is associated with alterations in lipid metabolism and gut microbiota dysbiosis. This study investigated the effects of puerarin, a bioactive isoflavone, on lipid metabolism disorders and gut microbiota in high-fat diet (HFD)-induced obese mice. Supplementation with puerarin reduced plasma alanine aminotransferase, liver triglyceride, liver free fatty acid (FFA), and improved gut microbiota dysbiosis in obese mice. Puerarin’s beneficial metabolic effects were attenuated when farnesoid X receptor (FXR) was antagonized, suggesting FXR-mediated mechanisms. In hepatocytes, puerarin ameliorated high FFA-induced sterol regulatory element-binding protein (SREBP) 1 signaling, inflammation, and mitochondrial dysfunction in an FXR-dependent manner. In obese mice, puerarin reduced liver damage, regulated hepatic lipogenesis, decreased inflammation, improved mitochondrial function, and modulated mitophagy and ubiquitin-proteasome pathways, but was less effective in FXR knockout mice. Puerarin upregulated hepatic expression of FXR, bile salt export pump (BSEP), and downregulated cytochrome P450 7A1 (CYP7A1) and sodium taurocholate transporter (NTCP), indicating modulation of bile acid synthesis and transport. Puerarin also restored gut microbial diversity, the Firmicutes/Bacteroidetes ratio, and the abundance of Clostridium celatum and Akkermansia muciniphila. This study demonstrates that puerarin effectively ameliorates metabolic disturbances and gut microbiota dysbiosis in obese mice, predominantly through FXR-dependent pathways. These findings underscore puerarin’s potential as a therapeutic agent for managing obesity and enhancing gut health, highlighting its dual role in improving metabolic functions and modulating microbial communities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoflavonesGastrointestinal MicrobiomeDiet, High-FatReceptors, Cytoplasmic and NuclearObesityLiverAnimalsMiceMaleDysbiosisMice, ObeseMice, Inbred C57BLATP Binding Cassette Transporter, Subfamily B, Member 11Cholesterol 7-alpha-HydroxylaseMice, KnockoutOrganic Anion Transporters, Sodium-DependentSymportersLipid MetabolismHepatocytesAkkermansiaReceptor, Farnesoid X-Activated

Stichwörter der Autor:innen

farnesoid X receptorgut microbiotamitochondrial functionmitophagyobesepuerarin

Substanzen

IsoflavonesReceptors, Cytoplasmic and NuclearATP Binding Cassette Transporter, Subfamily B, Member 11Cholesterol 7-alpha-HydroxylaseOrganic Anion Transporters, Sodium-DependentSymportersReceptor, Farnesoid X-ActivatedpuerarinCyp7a1 protein, mousesodium-bile acid cotransporter

Autor:innen und Institutionen

  • Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
  • Division of Internal and Pediatric Chinese Medicine, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Linkou 333423, Taiwan.
  • Graduate Institute of Traditional Chinese Medicine, School of Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
  • Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Keelung 20401, Taiwan.
  • School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan.
  • Division of Acupuncture and Moxibustion, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan 333423, Taiwan.

ORCID-Profile: Ching-Wei Yang, Hsuan-Miao Liu, Zi-Yu Chang, Geng-Hao Liu, Hen-Hong Chang, Tzung-Yan Lee

Förderung

  • Chang Gung Memorial Hospital, Linkou, Taiwan
  • National Science and Technology Council, Taipei, Taiwan

Zitieren

APA

Yang, C. W., Liu, H. M., Chang, Z. Y., Liu, G. H., Chang, H. H., Huang, P. Y., & Lee, T. Y. (2024). Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice. International Journal of Molecular Sciences, 25(10), 5274. https://doi.org/10.3390/ijms25105274

Vancouver

Yang CW, Liu HM, Chang ZY, Liu GH, Chang HH, Huang PY, et al. Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice. International Journal of Molecular Sciences. 2024;25(10):5274. doi:10.3390/ijms25105274

BibTeX
@article{Yang2024,
  author = {Yang, Ching-Wei and Liu, Hsuan-Miao and Chang, Zi-Yu and Liu, Geng-Hao and Chang, Hen-Hong and Huang, Po-Yu and Lee, Tzung-Yan},
  title = {Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {10},
  pages = {5274},
  doi = {10.3390/ijms25105274}
}
Kostenlos starten →